Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial

Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T21:29:02.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears at the top of the page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1.0%
    Check dated 2026-10-20T21:53:49.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T21:50:45.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The record history adds a new revision entry for v3.7.0. The previous revision entry v3.6.6 is removed.
    Difference
    0.1%
    Check dated 2026-09-15T21:38:05.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the study record history. The previous revision entry v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-09-01T19:27:22.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    An additional revision entry, v3.6.5, has been added to the study's history, updating the version list. This change reflects an update to the record's metadata rather than substantive study content.
    Difference
    0.1%
    Check dated 2026-08-11T08:20:46.000Z thumbnail image

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.